Hellenic Dynamics (HELD) Competitors GBX 0.0095 0.00 (0.00%) As of 07/7/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsBuy This Stock HELD vs. HLN, BXP, HIK, HCM, INDV, AMYT, AGY, APH, ANCR, and VLGShould you be buying Hellenic Dynamics stock or one of its competitors? The main competitors of Hellenic Dynamics include Haleon (HLN), Beximco Pharmaceuticals (BXP), Hikma Pharmaceuticals (HIK), HUTCHMED (HCM), Indivior (INDV), Amryt Pharma (AMYT), Allergy Therapeutics (AGY), Alliance Pharma (APH), Animalcare Group (ANCR), and Venture Life Group (VLG). These companies are all part of the "drug manufacturers - specialty & generic" industry. Hellenic Dynamics vs. Its Competitors Haleon Beximco Pharmaceuticals Hikma Pharmaceuticals HUTCHMED Indivior Amryt Pharma Allergy Therapeutics Alliance Pharma Animalcare Group Venture Life Group Hellenic Dynamics (LON:HELD) and Haleon (LON:HLN) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, risk, dividends, valuation, media sentiment, analyst recommendations, earnings and institutional ownership. Is HELD or HLN more profitable? Haleon has a net margin of 9.66% compared to Hellenic Dynamics' net margin of 0.00%. Haleon's return on equity of 6.54% beat Hellenic Dynamics' return on equity.Company Net Margins Return on Equity Return on Assets Hellenic DynamicsN/A -364.21% N/A Haleon 9.66%6.54%4.45% Which has stronger valuation & earnings, HELD or HLN? Haleon has higher revenue and earnings than Hellenic Dynamics. Hellenic Dynamics is trading at a lower price-to-earnings ratio than Haleon, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioHellenic DynamicsN/AN/A-£5.22M-£3.550.00Haleon£11.07B3.01£1.07B£11.8931.09 Do insiders and institutionals hold more shares of HELD or HLN? 0.1% of Hellenic Dynamics shares are held by institutional investors. Comparatively, 43.9% of Haleon shares are held by institutional investors. 72.9% of Hellenic Dynamics shares are held by insiders. Comparatively, 10.7% of Haleon shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts recommend HELD or HLN? Haleon has a consensus price target of GBX 457, suggesting a potential upside of 23.61%. Given Haleon's stronger consensus rating and higher probable upside, analysts plainly believe Haleon is more favorable than Hellenic Dynamics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Hellenic Dynamics 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Haleon 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00 Does the media prefer HELD or HLN? In the previous week, Hellenic Dynamics' average media sentiment score of 0.00 beat Haleon's score of -0.74 indicating that Hellenic Dynamics is being referred to more favorably in the media. Company Overall Sentiment Hellenic Dynamics Neutral Haleon Negative SummaryHaleon beats Hellenic Dynamics on 11 of the 13 factors compared between the two stocks. Get Hellenic Dynamics News Delivered to You Automatically Sign up to receive the latest news and ratings for HELD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding HELD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart HELD vs. The Competition Export to ExcelMetricHellenic DynamicsDrug Manufacturers IndustryMedical SectorLON ExchangeMarket Cap£14K£2.16B£5.50B£2.97BDividend YieldN/A2.92%5.25%5.02%P/E Ratio0.004.1426.97151.95Price / SalesN/A538.15426.02249,943.19Price / CashN/A10.3536.8227.97Price / Book0.0111.677.984.56Net Income-£5.22M£21.15B£3.16B£5.90B7 Day PerformanceN/A1.53%2.36%1.78%1 Month PerformanceN/A6.21%2.15%4.51%1 Year PerformanceN/A3.95%33.78%80.51% Hellenic Dynamics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)HELDHellenic DynamicsN/AGBX 0.01flatN/AN/A£14KN/A0.00N/AHLNHaleon1.3177 of 5 starsGBX 373.10+0.2%GBX 457+22.5%+12.6%£33.67B£11.07B31.3825,408BXPBeximco PharmaceuticalsN/AGBX 34.26-2.1%N/AN/A£23.35B£7.08T3.685,500Positive NewsGap DownHIKHikma Pharmaceuticals3.8004 of 5 starsGBX 1,987.94+0.4%GBX 2,560+28.8%+9.2%£5.51B£3.74B19.519,100HCMHUTCHMEDN/AGBX 230+4.1%N/A-11.3%£2.50B£771.01M-58.701,760Gap UpINDVIndivior2.911 of 5 starsGBX 1,130+0.9%GBX 1,650+46.0%-4.3%£1.77B£1.40B-936.931,000AMYTAmryt PharmaN/AN/AN/AN/A£457.11M£210.24M-4.33290Gap DownAGYAllergy TherapeuticsN/AGBX 8flatN/A+62.0%£393.21M£72.18M-7.71612News CoverageAPHAlliance Pharma2.1277 of 5 starsGBX 64.70flatGBX 6,250+9,560.0%N/A£350.32M£183.50M-10.4391,000ANCRAnimalcare GroupN/AGBX 294-0.3%N/A+25.4%£201.57M£84.90M5.48220Gap DownHigh Trading VolumeVLGVenture Life GroupN/AGBX 60.98+3.3%N/A+36.6%£77.70M£51.77M103.48165Positive NewsHigh Trading Volume Related Companies and Tools Related Companies Haleon Competitors Beximco Pharmaceuticals Competitors Hikma Pharmaceuticals Competitors HUTCHMED Competitors Indivior Competitors Amryt Pharma Competitors Allergy Therapeutics Competitors Alliance Pharma Competitors Animalcare Group Competitors Venture Life Group Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (LON:HELD) was last updated on 7/9/2025 by MarketBeat.com Staff From Our PartnersA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredThe DOJ Just Paved the Way for Account SeizuresWashington is running out of money…And guess where they'll look next? When governments go broke, they take ...Priority Gold | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Hellenic Dynamics Plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Hellenic Dynamics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free HELD Stock Alerts